Please login to the form below

Not currently logged in
Email:
Password:

benign prostatic hyperplasia

This page shows the latest benign prostatic hyperplasia news and features for those working in and with pharma, biotech and healthcare.

Witty says Chinese bribery probe will impact GSK

Witty says Chinese bribery probe will impact GSK

Among other products, benign prostatic hyperplasia drug Avodart (dutasteride) had a good quarter, rising 12 per cent to £221m, while sales of Benlysta (belimumab) for lupus more than doubled to £38m

Latest news

More from news
Approximately 2 fully matching, plus 32 partially matching documents found.

Latest Intelligence

  • Interview: Giovanni Recordati Interview: Giovanni Recordati

    The company also has long expertise in urology. “ We are currently rolling out a new drug for the treatment of benign prostatic hyperplasia and will soon be starting the last phase

  • Interview: Jorge Gallardo, Almirall Interview: Jorge Gallardo, Almirall

    The year's sales evolution has benefited from the launches of new products Silodyx (for benign prostatic hyperplasia, licence from Recordati) and Conbriza  (for osteoporosis, in co-promotion with Pfizer) in

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics